Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
8.53
-0.27 (-3.07%)
Feb 28, 2025, 2:45 PM CST
SHE:300009 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 14,231 | 17,094 | 15,623 | 21,448 | 20,044 | 15,849 | Upgrade
|
Market Cap Growth | -1.02% | 9.42% | -27.16% | 7.00% | 26.47% | 18.95% | Upgrade
|
Enterprise Value | 13,212 | 16,089 | 14,822 | 20,627 | 19,445 | 15,561 | Upgrade
|
Last Close Price | 8.53 | 9.84 | 8.79 | 12.03 | 11.14 | 8.74 | Upgrade
|
PE Ratio | 18.16 | 20.18 | 22.21 | 103.80 | 55.84 | 127.34 | Upgrade
|
Forward PE | - | 28.35 | 28.35 | 35.62 | 43.82 | 36.81 | Upgrade
|
PS Ratio | 5.14 | 5.97 | 6.70 | 9.89 | 11.78 | 9.25 | Upgrade
|
PB Ratio | 3.74 | 4.35 | 4.59 | 7.39 | 6.84 | 5.87 | Upgrade
|
P/TBV Ratio | 4.77 | 5.31 | 5.43 | 8.24 | 8.58 | 7.50 | Upgrade
|
P/FCF Ratio | 23.89 | 22.56 | 69.55 | 46.53 | 61.43 | 145.21 | Upgrade
|
P/OCF Ratio | 21.97 | 17.94 | 22.35 | 36.22 | 43.12 | 53.61 | Upgrade
|
EV/Sales Ratio | 4.78 | 5.61 | 6.36 | 9.51 | 11.43 | 9.09 | Upgrade
|
EV/EBITDA Ratio | 14.23 | 15.99 | 17.73 | 30.48 | 42.03 | 33.69 | Upgrade
|
EV/EBIT Ratio | 16.16 | 17.62 | 19.61 | 34.42 | 49.02 | 38.95 | Upgrade
|
EV/FCF Ratio | 22.18 | 21.24 | 65.98 | 44.75 | 59.60 | 142.56 | Upgrade
|
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | Upgrade
|
Debt / EBITDA Ratio | 0.06 | 0.06 | 0.04 | 0.04 | 0.03 | 0.06 | Upgrade
|
Debt / FCF Ratio | 0.09 | 0.07 | 0.15 | 0.06 | 0.04 | 0.26 | Upgrade
|
Asset Turnover | 0.58 | 0.62 | 0.59 | 0.60 | 0.51 | 0.60 | Upgrade
|
Inventory Turnover | 2.28 | 2.83 | 2.62 | 2.59 | 2.61 | 3.44 | Upgrade
|
Quick Ratio | 2.66 | 2.43 | 2.45 | 2.74 | 3.10 | 3.21 | Upgrade
|
Current Ratio | 3.20 | 2.75 | 2.83 | 3.07 | 3.47 | 3.56 | Upgrade
|
Return on Equity (ROE) | 20.21% | 23.41% | 23.40% | 6.97% | 12.31% | 4.69% | Upgrade
|
Return on Assets (ROA) | 10.67% | 12.39% | 11.92% | 10.44% | 7.37% | 8.68% | Upgrade
|
Return on Capital (ROIC) | 12.86% | 15.37% | 14.84% | 12.75% | 8.74% | 10.32% | Upgrade
|
Return on Capital Employed (ROCE) | 19.06% | 22.25% | 21.10% | 19.70% | 13.08% | 14.21% | Upgrade
|
Earnings Yield | 5.50% | 4.96% | 4.50% | 0.96% | 1.79% | 0.79% | Upgrade
|
FCF Yield | 4.19% | 4.43% | 1.44% | 2.15% | 1.63% | 0.69% | Upgrade
|
Dividend Yield | 2.27% | 2.54% | 2.84% | 1.66% | 1.50% | 1.10% | Upgrade
|
Payout Ratio | 52.83% | 48.52% | 46.58% | 132.37% | 44.35% | 130.01% | Upgrade
|
Buyback Yield / Dilution | -0.64% | -1.57% | -2.90% | 2.58% | 1.68% | -5.12% | Upgrade
|
Total Shareholder Return | 1.63% | 0.97% | -0.05% | 4.25% | 3.18% | -4.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.